These findings are consistent with previous studies reporting reduced expression of mitochondrial β-oxidation-related genes, such as PPARα, PGC1α, and CPT1A, in patients with fatty liver [24,41,42,43]. The gene discussed is PPARGC1A; the disease is Hepatic steatosis.